We are happy to announce that the Dutch Operator Fund has made its inaugural investment in the innovative health-tech startup, Fellos. This marks a significant milestone for our fund as we embark on our mission to support and scale promising Dutch startups.
Fellos addresses a critical gap in men's healthcare by providing a discreet online platform where men can consult with licensed Dutch physicians about sensitive health issues such as erectile dysfunction, hair loss, and acne. Recognizing that many men are reluctant to discuss these concerns with their general practitioners, Fellos offers an alternative that emphasizes privacy and convenience.
Through the platform, users can engage in confidential consultations via chat or video call. If medication is prescribed, it is delivered directly to the patient's address through a partnered pharmacy, ensuring a seamless and secure experience.
The founders of Fellos, Sibren Tolsma and Rob Smeitink, were inspired to create this service after observing that many individuals resort to unregulated sources, such as counterfeit medications, due to embarrassment or lack of access to proper medical advice. Their goal is to eliminate the stigma associated with men's health issues and provide a trustworthy solution.
Our investment in Fellos reflects our confidence in their mission and the potential impact of their services. We are committed to supporting their growth and helping them reach more individuals who can benefit from their innovative approach to healthcare.
This partnership exemplifies the Dutch Operator Fund's dedication to empowering startups that offer meaningful solutions to real-world problems. We look forward to collaborating with Fellos and witnessing their continued success in transforming men's healthcare in the Netherlands and beyond.
Fellos
